Will Cannabis Genetics Be Restricted?<

Will Cannabis Genetics Be Restricted?

The redefinition of hemp under federal law, scheduled to take effect Nov. 12, signals the end of Farm Bill protections for many hemp-derived THC products across the nation: low-dose beverages as well as THCA bud and delta-8 THC edibles, vapes and additional products sold at gas stops and smoke shops.

But the hemp ban also creates a significant complication for the legitimate cannabis industry. Seeds from cannabis cultivars that generate flower with greater than 0.3% THC are no longer legal to ship out of state.

Although seed purchases will likely continue in authorized states, the modifications threaten to shutter some seed banks and genetics companies, observers note, while creating supply-chain problems for cannabis cultivators and retailers.

“If this wording goes forward, we will require pop-up shops to offer seeds in each state where it’s legal,” Campanella said. “Which is why we’re also providing clones and tissue culture, because that’s not covered in the bill.”

When are cannabis genetics and clones illegal to ship across state lines?

The updated regulations classify seeds based on the THC potential of the parent plant. Genetic substances such as seeds and https://nativesusa.com/, clones are made illegal if the final product exceeds the threshold.

For the moment, seeds are currently shipping under the 2018 Farm Bill’s status quo. But the clock is ticking for businesses like Brothers Grimm and for cannabis growers who fear supply chain interruptions if out-of-state availability to genetics is banned.

Most of the cannabis sector remains largely unaware of the approaching shutdown of the interstate genetics market, said Ryan Power, cofounder of Sebastopol, California-based breeder Atlas Seed.

Without government intervention in the way of a carve-out for seeds or a general moratorium, many seed suppliers will just be shuttered by November, he added.

“We are operating legally now, but if that changes, it will upend the legal licensed sector in each state,” said Power, whose clientele includes seed suppliers as well as licensed commercial cultivators.

“Customers are going to lose choice, and it will be a significant shutdown for many people.”

What are cannabis seed suppliers doing to stay legal after the federal hemp ban?

Sagui Silber has already recalibrated Silberhaze Genetics, his Ohio genetics company, because of state Senate Bill 56, which strengthened cannabis oversight in that state while also restricting hemp-derived THC items to licensed cannabis retailers.

Formerly a seed bank, Silberhaze is currently focused on the marketing, preservation and IP safeguarding of premium plant genetics.

That’s because seed companies hoping to remain compliant in this updated environment must have solid documentation, he said.

“You have to demonstrate where this material comes from, so it’s very important to have records, even to the extent where you have cultivator names,” Silber said.

“Small businesses will have to operate with better records and a better chain of custody,” he added. “We need that documentation ourselves, because we don’t want to be dealing with shady sources.”

To avoid seizures and additional legal consequences, seed entrepreneurs must “get their affairs in order” before the new regulations take effect, Silber said.

“Audit all your materials immediately, and classify what you can,” Silber said. “Take inventory, document your lineage, preserve breeder records, and organize any cannabinoid or terpene data you already have. If regulations shift, you’ll be in a much better position to comprehend what may be affected and make informed decisions.”

Does federal marijuana rescheduling affect cannabis genetics?

Silber believes U.S. Drug Enforcement Administration registration may be required for companies engaged in research.

But for the time being, seed houses can’t register with the DEA like state-licensed medical cannabis operators can. Such an option is not available to seed banks, nurseries or genetics businesses, said Jim Ickes, a lawyer and partner with Frantz Ward’s cannabis law group in Cleveland.

“Seed-related activity may be happening inside larger state-licensed medical marijuana operations, as some states allow dispensaries or registered medical operators to sell seeds, clones or home-cultivation materials,” he said.

“But that is different from the DEA establishing a freestanding seed supplier registration category.”

Some genetics operators are currently changing operational practices to conform with the updated law. According to Ickes, they must answer questions including:

• Which of our lines produce plants over 0.3% total THC?
• Which seeds survive as hemp after Nov. 12, 2026, and which don’t?
• What does our inventory look like once we sort it against the viable-seed exclusion?

Ickes also understands confusion from clients who believed government rescheduling of medical marijuana would clarify their situation with banking institutions. However, the latest regulatory language has moved those conversations past the basics of classification, he said.

“Banks ask whether this specific revenue source is lawful, whether it ties to state-licensed activity, or whether there’s cross-state risk,” said Ickes.

“After November, a seed bank selling drug-type genetics can’t address the first question with the hemp classification. It has to point to a legal state cannabis channel instead. Seed suppliers dealing in genuine industrial-hemp seed maintain the simpler story.”

What’s the future of cannabis genetics?

Campanella is part of a emerging coalition of other breeders, farmers and researchers that’s arguing seeds are more appropriately defined as farm inputs than regulated substances. To that end, seeds should be overseen by the U.S. Department of Agriculture, leaving the DEA to focus its enforcement efforts elsewhere.

“How do you regulate something based on what it might become later?” said Campanella. “Our preference is to have that wording removed, or get seeds regulated by the USDA as a hemp product.”

But in the meantime, Campanella is reorganizing Brothers Grimm to operate outside the reach of changing federal oversight. The business plans to maintain its Colorado seed facility while placing its Oklahoma tissue culture facility as a safeguard against government prohibition of cannabis seeds.

As she noted: “If things develop in a way where we can’t concentrate on interstate shipping, we’ll have other resources to satisfy people’s requirements without putting ourselves in trouble.”